Cover Image
市場調查報告書

英國的髖關節置換市場預測

United Kingdom Hip Reconstruction Market Outlook to 2021

出版商 GlobalData 商品編碼 294523
出版日期 內容資訊 英文 66 Pages
訂單完成後即時交付
價格
Back to Top
英國的髖關節置換市場預測 United Kingdom Hip Reconstruction Market Outlook to 2021
出版日期: 2015年08月01日 內容資訊: 英文 66 Pages
簡介

本報告提供英國的髖關節置換市場相關調查分析,提供各市場區隔的主要市場資料(收益,數量,平均價格,企業佔有率,流通佔有率)資料,加上主要企業簡介等,為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 英國的髖關節置換市場

  • 收益(實際成果)
  • 收益(預測)
  • 數量(實際成果)
  • 數量(預測)
  • 平均價格
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第4章 英國的髖關節置換設備市場上主要企業概要

  • DePuy Companies
  • Zimmer Holdings, Inc.
  • Stryker Corporation
  • Biomet, Inc.
  • Smith & Nephew Plc
  • Wright Medical Group, Inc.
  • Corin Group PLC
  • B. Braun Melsungen AG
  • Exactech, Inc.

第5章 髖關節置換市場開發中產品

第6章 最近的趨勢

  • 企業宣傳
  • 決算發表
  • 法律規章
  • 其他的重要的趨勢
  • 產品新聞

第7章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDMECC1034DB

GlobalData's new report, "United Kingdom Hip Reconstruction Market Outlook to 2021", provides key market data on the United Kingdom Hip Reconstruction market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments - Primary Hip Replacement, Partial Hip Replacement, Revision Hip Replacement and Hip Resurfacing.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Hip Reconstruction market segments - Primary Hip Replacement, Partial Hip Replacement, Revision Hip Replacement and Hip Resurfacing.
  • Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Hip Reconstruction market.
  • Global corporate-level profiles of key companies operating within the United Kingdom Hip Reconstruction market.
  • Key players covered include Zimmer Holdings, Inc., Stryker Corporation, DePuy Companies, Smith & Nephew Plc, Biomet, Inc. and Wright Medical Group, Inc.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Hip Reconstruction Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Hip Reconstruction Market, United Kingdom

  • 3.1. Hip Reconstruction Market, United Kingdom, Revenue ($m), 2007-2014
  • 3.2. Hip Reconstruction Market, United Kingdom, Revenue ($m), 2014-2021
    • 3.2.1. Partial Hip Replacement Market, United Kingdom, Revenue ($m), by Segment, 2007-2014
    • 3.2.2. Primary Hip Replacement Market, United Kingdom, Revenue ($m), by Segment, 2007-2014
    • 3.2.3. Partial Hip Replacement Market, United Kingdom, Revenue ($m), by Segment, 2014-2021
    • 3.2.4. Primary Hip Replacement Market, United Kingdom, Revenue ($m), by Segment, 2014-2021
  • 3.3. Hip Reconstruction Market, United Kingdom, Volume (Units), 2007-2014
  • 3.4. Hip Reconstruction Market, United Kingdom, Volume (Units), 2014-2021
    • 3.4.1. Partial Hip Replacement Market, United Kingdom, Volume (Units), by Segment, 2007-2014
    • 3.4.2. Primary Hip Replacement Market, United Kingdom, Volume (Units), by Segment, 2007-2014
    • 3.4.3. Partial Hip Replacement Market, United Kingdom, Volume (Units), by Segment, 2014-2021
    • 3.4.4. Primary Hip Replacement Market, United Kingdom, Volume (Units), by Segment, 2014-2021
  • 3.5. Hip Reconstruction Market, United Kingdom, Average Price ($), 2007-2021
  • 3.6. Hip Reconstruction Market, United Kingdom, Distribution Share by Revenue ($m), 2014
  • 3.7. Hip Reconstruction Market, United Kingdom, Company Share by Revenue ($m), 2014

4. Overview of Key Companies in United Kingdom, Hip Reconstruction Market

  • 4.1. DePuy Companies
    • 4.1.1. Company Overview
  • 4.2. Zimmer Biomet Holdings, Inc.
    • 4.2.1. Company Overview
  • 4.3. Stryker Corporation
    • 4.3.1. Company Overview
  • 4.4. Smith & Nephew Plc
    • 4.4.1. Company Overview
  • 4.5. Biomet, Inc. (Inactive)
    • 4.5.1. Company Overview
  • 4.6. B. Braun Melsungen AG
    • 4.6.1. Company Overview
  • 4.7. MicroPort Scientific Corporation
    • 4.7.1. Company Overview
  • 4.8. Corin Group Plc
    • 4.8.1. Company Overview

5. Hip Reconstruction Market Pipeline Products

6. Financial Deals Landscape

  • 6.1. Acquisition
    • 6.1.1. Stryker Rumored to Bid for Smith & Nephew
  • 6.2. Debt Offerings
    • 6.2.1. Smith & Nephew to Raise USD730 Million in Debt Placement of 3.1% Due 2022
    • 6.2.2. Smith & Nephew to Raise USD70 Million in Debt Placement
  • 6.3. Partnerships
    • 6.3.1. DePuy Synthes Enters into Agreement with Radlink

7. Recent Developments

  • 7.1. Corporate Communications
    • 7.1.1. Jul 14, 2015: Smith & Nephew Announces Passing Of John Buchanan
    • 7.1.2. Dec 04, 2014: Brainsway Receives CE Approval for Deep TMS System - OCD
    • 7.1.3. Nov 13, 2014: Appointment of Erik Engstrom as Non-Executive Director
    • 7.1.4. Nov 13, 2014: Smith & Nephew Announces Appointment Of Erik Engstrom As Non-Executive Director
    • 7.1.5. Oct 30, 2014: Appointment of Vinita Bali as Non-Executive Director
    • 7.1.6. Oct 30, 2014: Smith & Nephew Announces Appointment of Vinita Bali as Non-Executive Director
    • 7.1.7. Aug 01, 2014: Smith & Nephew Announces Directorate Change
    • 7.1.8. Jul 24, 2014: New clinical data shows PICO canister-free NPWT system has positive benefits for high-risk orthopaedic patients
  • 7.2. Financial Announcements
    • 7.2.1. Apr 15, 2015: Cara Therapeutics to Present at 3rd Conference on the Therapeutic Potential of Kappa Opioids
    • 7.2.2. Feb 05, 2015: Smith & Nephew Announces results for Q4 and Full Year
    • 7.2.3. Oct 30, 2014: Smith & Nephew 2014 Q3 Results
    • 7.2.4. Jul 31, 2014: Smith & Nephew Reported 2014 Q2 Results
  • 7.3. Other Significant Developments
    • 7.3.1. Oct 29, 2014: Smith & Nephew Announces Sterling Amount Of Dividend
  • 7.4. Product News
    • 7.4.1. Jun 17, 2015: Smith & Nephew Receives $99 Million Patent Infringement Payment from Arthrex

8. Appendix

  • 8.1. Research Methodology
    • 8.1.1. Coverage
    • 8.1.2. Secondary Research
    • 8.1.3. Primary Research
    • 8.1.4. Market Modeling and Forecasting
    • 8.1.5. Company Share Analysis
    • 8.1.6. Distribution Share Analysis
  • 8.2. Expert Panel
  • 8.3. GlobalData Consulting
  • 8.4. Contact Us
  • 8.5. Disclaimer

List of Tables

  • Table 1: Hip Reconstruction Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 2: Hip Reconstruction Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 3: Partial Hip Replacement Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 4: Primary Hip Replacement Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 5: Partial Hip Replacement Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 6: Primary Hip Replacement Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 7: Hip Reconstruction Market, United Kingdom, Volume (Units), Historic, 2007-2014
  • Table 8: Hip Reconstruction Market, United Kingdom, Volume (Units), Forecast, 2014-2021
  • Table 9: Partial Hip Replacement Market, United Kingdom, Volume (Units), Historic, 2007-2014
  • Table 10: Primary Hip Replacement Market, United Kingdom, Volume (Units), Historic, 2007-2014
  • Table 11: Partial Hip Replacement Market, United Kingdom, Volume (Units), Forecast, 2014-2021
  • Table 12: Primary Hip Replacement Market, United Kingdom, Volume (Units), Forecast, 2014-2021
  • Table 13: Hip Reconstruction Market, United Kingdom, Average Price ($), Historic, 2007-2014
  • Table 14: Hip Reconstruction Market, United Kingdom, Average Price ($), Forecast, 2014-2021
  • Table 15: Hip Reconstruction Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 16: Hip Reconstruction Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2014
  • Table 17: Hip Reconstruction Market Pipeline Products
  • Table 18: Stryker Rumored to Bid for Smith & Nephew
  • Table 19: Smith & Nephew to Raise USD730 Million in Debt Placement of 3.1% Due 2022
  • Table 20: Smith & Nephew to Raise USD70 Million in Debt Placement
  • Table 21: DePuy Synthes Enters into Agreement with Radlink
  • Table 22: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country

List of Figures

  • Figure 1: Hip Reconstruction Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 2: Hip Reconstruction Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 3: Partial Hip Replacement Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 4: Primary Hip Replacement Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 5: Partial Hip Replacement Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 6: Primary Hip Replacement Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 7: Hip Reconstruction Market, United Kingdom, Volume (Units), Historic, 2007-2014
  • Figure 8: Hip Reconstruction Market, United Kingdom, Volume (Units), Forecast, 2014-2021
  • Figure 9: Partial Hip Replacement Market, United Kingdom, Volume (Units), Historic, 2007-2014
  • Figure 10: Primary Hip Replacement Market, United Kingdom, Volume (Units), Historic, 2007-2014
  • Figure 11: Partial Hip Replacement Market, United Kingdom, Volume (Units), Forecast, 2014-2021
  • Figure 12: Primary Hip Replacement Market, United Kingdom, Volume (Units), Forecast, 2014-2021
  • Figure 13: Hip Reconstruction Market, United Kingdom, Company Share (%) 2014
  • Figure 14: GlobalData Epidemiology-Based Forecasting Model
  • Figure 15: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 16: Primary Interviews by Participant Type (%)
Back to Top